EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy

L Madeline McCrary iD, Megan R Curtis iD, Jeannie C Kelly, Jessica Elrod-Gallegos, Patrick Kojima iD, Patricia Werner, Jennifer L Mullersman iD, Tracey Habrock-Bach, Michael J Durkin, Laura R Marks

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von L Madeline McCrary und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Benzimidazoles, Sulfonamides, Antiviral Agents, Quinoxalines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIDA NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Guidelines endorse antenatal hepatitis C virus treatment following shared decision making. No clinical trial or real-world data exist for glecaprevir-pibrentasvir (GLE/PIB). We report our experience with prenatal GLE/PIB in 14 patients. Ten patients completed treatment; all achieved virologic response by or at delivery, with no maternal or neonatal safety concerns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzimidazolesSulfonamidesAntiviral AgentsQuinoxalinesPyrrolidinesPregnancy Complications, InfectiousHepatitis C, ChronicHepatitis CPiperidinesHumansFemalePregnancyAminoisobutyric AcidsAdultLeucineCyclopropanesProlineLactams, MacrocyclicTreatment OutcomeHepacivirus

Stichwörter der Autor:innen

direct-acting antiviralshepatitis Cperinatal infectionspregnancy

Substanzen

BenzimidazolesSulfonamidesAntiviral AgentsQuinoxalinesPyrrolidinesAminoisobutyric AcidsLeucineCyclopropanesProlineLactams, Macrocyclic

Autor:innen und Institutionen

  • Division of Infectious Diseases, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Division of Maternal-Fetal Medicine and Ultrasound, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Infectious Diseases Section, John Cochran Veterans Administration Medical Center, St Louis, Missouri, USA.

ORCID-Profile: L Madeline McCrary, Megan R Curtis, Patrick Kojima, Jennifer L Mullersman

Förderung

  • NIAID NIH HHS
  • NIDA NIH HHS
  • NICHD NIH HHS
  • NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute on Drug Abuse, NIH
  • National Institute of Allergy and Infectious Diseases, NIH
  • National Institutes of Health

Zitieren

APA

McCrary, L. M., Curtis, M. R., Kelly, J. C., Elrod-Gallegos, J., Kojima, P., Werner, P., Mullersman, J. L., Habrock-Bach, T., Durkin, M. J., & Marks, L. R. (2026). Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag422

Vancouver

McCrary LM, Curtis MR, Kelly JC, Elrod-Gallegos J, Kojima P, Werner P, et al. Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag422

BibTeX
@article{McCrary2026,
  author = {McCrary, L Madeline and Curtis, Megan R and Kelly, Jeannie C and Elrod-Gallegos, Jessica and Kojima, Patrick and Werner, Patricia and Mullersman, Jennifer L and Habrock-Bach, Tracey and Durkin, Michael J and Marks, Laura R},
  title = {Real-World Experience of Hepatitis C Treatment With Glecaprevir-Pibrentasvir During Pregnancy},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag422}
}
Kostenlos starten →